ID   CCD-33Co
AC   CVCL_2389
SY   CCD33Co
DR   CLO; CLO_0002317
DR   ATCC; CRL-1539
DR   JCRB; IFO50483
DR   Wikidata; Q54808892
RX   PubMed=15900046;
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (ATCC=CRL-1539).
CC   Karyotypic information: 47,XY,+7 [62%] (ATCC=CRL-1539).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC; JCRB
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 14,22
ST   D19S433: 15,16.2
ST   D21S11: 31,31.2
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 8,11
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2390 ! CCD-33Lu
OI   CVCL_U328 ! CCD-33Sk
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 13
//
RX   PubMed=15900046; DOI=10.1093/jnci/dji133;
RA   Mashima T., Oh-hara T., Sato S., Mochizuki M., Sugimoto Y.,
RA   Yamazaki K., Hamada J.-i., Tada M., Moriuchi T., Ishikawa Y., Kato Y.,
RA   Tomoda H., Yamori T., Tsuruo T.;
RT   "p53-defective tumors with a functional apoptosome-mediated pathway: a
RT   new therapeutic target.";
RL   J. Natl. Cancer Inst. 97:765-777(2005).
//